| abstract |
The subject of the present invention is alopecia, in particular alopecia areata, male androgenetic alopecia, female androgenetic alopecia, female alopecia, postpartum alopecia, seborrheic alopecia, erosive alopecia, Not only effective and safe for senile alopecia, cancer chemotherapeutic alopecia and alopecia due to radiation exposure, but also effective for subjects resistant to treatment with minoxidil and finasteride, itching and irritation To provide a new therapeutic agent for alopecia that has no side effects such as feminization, no contraindications, suppresses dandruff, has a gray hair treatment effect, and does not lose a baldness treatment effect for a long time even if it is discontinued. It is. The solution of the present invention comprises alopecia comprising as an active ingredient C-type natriuretic peptide (CNP) or B-type natriuretic peptide (BNP), derivatives of these NPs, chimeric peptides of these NPs or derivatives of these NP chimeric peptides. It is a therapeutic agent. |